MedTrace Logo

Emphasizing the Personal Versus the Social in Educational Interventions For Decreasing Vaccine Hesitancy

NCT05120817 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4000

Last updated 2021-11-15

No results posted yet for this study

Summary

This experimental study aims to investigate the effect of different types of educational interventions on overcoming Coronavirus disease 2019 (COVID-19) vaccine hesitancy among the Higher School of Economics (HSE) bachelor students in Russia.

Conditions

  • Vaccine Hesitancy
  • Communication

Interventions

BEHAVIORAL

"Personal" intervention

Participants will receive a link with an invitation to watch a 10-minute educational video about the personal benefits and costs of vaccination against COVID-19. They will also go through pre-and post-test data collection.

BEHAVIORAL

"Social" intervention

Participants will receive a link with an invitation to watch a 10-minute educational video about the social benefits and costs of vaccination against COVID-19. They will also go through pre-and post-test data collection.

BEHAVIORAL

"Personal" + "Social" intervention

Participants will receive a link with an invitation to watch a 10-minute educational video about both personal and social benefits and costs of vaccination against COVID-19. They will also go through pre-and post-test data collection.

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER

  • National Research University Higher School of Economics

    lead OTHER

Principal Investigators

  • Prashant Loyalka, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2022-01-31
Completion
2022-01-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120817 on ClinicalTrials.gov